SCHEMBL678342

SCHEMBL678342

CC(=O)c1ccc(CC(C)[Sb](C)C)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.53
LMNA P02545 4/20 0.52
PPARG P37231 1/20 0.50
PPARA Q07869 1/20 0.50
ACACB O00763 1/20 0.49
HPGD P15428 3/20 0.47
MEN1 O00255 1/20 0.47
ALDH1A1 P00352 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
MAPT P10636 2/20 0.44
RAB9A P51151 1/20 0.44
HSD17B10 Q99714 1/20 0.43
MAOB P27338 5/20 0.41
PYCR1 P32322 1/20 0.40
MMP12 P39900 1/20 0.40
MMP13 P45452 1/20 0.40
POLB P06746 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
MAOA P21397 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL678295 0.81 PPARG (0.50) LMNAPPARGPPARAHPGDALDH1A1
SCHEMBL677813 0.81 LOXL2 (0.54) KMT2AHPGDMEN1ALDH1A1SMN1; SMN2
SCHEMBL585471 0.80 LMNA (0.64) KMT2ALMNAACACBHPGDMEN1
SCHEMBL5693763 0.79 KMT2A (0.59) KMT2ALMNAPPARGPPARAACACB
SCHEMBL30885553 0.79 KMT2A (0.59) KMT2ALMNAPPARGPPARAACACB
Isobutylbenzene SCHEMBL9420396 0.78 LMNA (0.67) KMT2ALMNAPPARGPPARAACACB
SCHEMBL16773963 0.77 KMT2A (0.57) KMT2ALMNAPPARGPPARAACACB
SCHEMBL8136474 0.77 TAAR1 (0.59) KMT2AACACBMAOA
SCHEMBL2331619 0.77 KMT2A (0.57) KMT2ALMNAPPARGPPARAACACB
SCHEMBL11632648 0.77 KMT2A (0.57) KMT2ALMNAPPARGPPARAACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110275774-A1 ORGANOANTIMONY COMPOUND, PROCESS FOR PREPARING SAME, LIVING RADICAL POLYMERIZATION INITIATOR, PROCESS FOR PRODUCING POLYMER WITH USE OF SAME, AND THE POLYMER YAMAGO SHIGERU 2011-11-10 US disclosed
US-8008414-B2 Organic antimony compound, process for producing the same, living radical polymerization initiator, process for producing polymer using the same, and polymer OTSUKA CHEMICAL CO., LTD. (JP) 2011-08-30 US disclosed
EP-1767539-B1 ORGANIC ANTIMONY COMPOUND, PROCESS FOR PRODUCING THE SAME, LIVING RADICAL POLYMERIZATION INITIATOR, PROCESS FOR PRODUCING POLYMER USING THE SAME, AND POLYMER OTSUKA CHEMICAL CO LTD (JP) 2011-07-27 EP disclosed
US-20090299008-A1 Organic antimony compound, process for producing the same, living radical polymerization initiator, process for producing polymer using the same, and polymer OTSUKA CHEMICAL CO., LTD. (JP) 2009-12-03 US disclosed
EP-1767539-A1 ORGANIC ANTIMONY COMPOUND, PROCESS FOR PRODUCING THE SAME, LIVING RADICAL POLYMERIZATION INITIATOR, PROCESS FOR PRODUCING POLYMER USING THE SAME, AND POLYMER OTSUKA CHEMICAL COMPANY, LTD. (JP) 2007-03-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090299008-A1 Organic antimony compound, process for producing the same, living radical polymerization initiator, process for producing polymer using the same, and polymer AOC2, ODC1, MCM7 KMT2A 1071/4885LMNA 1912/4885PPARG 4044/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.